Caribou Biosciences (CRBU) Accumulated Expenses (2020 - 2026)
Caribou Biosciences (CRBU) recorded Accumulated Expenses of $13.15 million in Q2 2026, down 36.0% from $20.53 million a year earlier and down 5.4% from the prior quarter.
Powered by 
Analysis
Caribou Biosciences (CRBU) Accumulated Expenses (2020 - 2026) Analysis & Trends
At the end of FY2025, Caribou Biosciences reported Accumulated Expenses of $16.54 million, down 30.0% from FY2024.
- Annual Accumulated Expenses has a five-year compound annual growth rate of 13.0% (FY2020 to FY2025).
- Across earlier years, Accumulated Expenses came in at $23.62 million in FY2024 (+11.8%), $21.14 million in FY2023 (+31.4%), $16.08 million in FY2022 (+22.4%) and $13.14 million in FY2021 (+46.4%).
- The Q2 2026 figure is the lowest quarterly Accumulated Expenses since Q1 2023.
- On a year-over-year basis, Accumulated Expenses has declined for five consecutive quarters, with an average decline of 9.6% over the last eight quarters.
- Peak year-over-year performance for Accumulated Expenses in the last five years was growth of 51.4% in Q1 2024, against a decline of 36.0% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $13.89 million (Q1 2026), $16.54 million (Q4 2025) and $19.35 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Caribou Biosciences | 134.61 Mn | -381.92 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.15 Mn |
| Mar 31, 2026 | 13.89 Mn |
| Dec 31, 2025 | 16.54 Mn |
| Sep 30, 2025 | 19.35 Mn |
| Jun 30, 2025 | 20.53 Mn |
| Mar 31, 2025 | 19.89 Mn |
| Dec 31, 2024 | 23.62 Mn |
| Sep 30, 2024 | 25.45 Mn |
| Jun 30, 2024 | 23.63 Mn |
| Mar 31, 2024 | 18.99 Mn |
| Dec 31, 2023 | 21.14 Mn |
| Sep 30, 2023 | 18.23 Mn |
| Jun 30, 2023 | 15.90 Mn |
| Mar 31, 2023 | 12.54 Mn |
| Dec 31, 2022 | 16.08 Mn |
| Sep 30, 2022 | 14.64 Mn |
| Jun 30, 2022 | 14.91 Mn |
| Mar 31, 2022 | 11.19 Mn |
| Dec 31, 2021 | 13.14 Mn |
| Sep 30, 2021 | 13.93 Mn |
API Access
Caribou Biosciences Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CRBU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "CRBU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CRBU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();